FLXN
Flexion Therapeutics Inc
Halal Rating :
Last Price
$9.19
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Note: Flexion Therapeutics was acquired by Pacira BioSciences (NASDAQ: PCRX) in November 2021. The merger was completed and FLXN stock is no longer traded.
Prior to acquisition, Flexion Therapeutics was a biopharmaceutical company focused on developing and commercializing novel, local therapies for the treatment of patients with musculoskeletal conditions. Their lead product was ZILRETTA, an extended-release corticosteroid for knee osteoarthritis pain.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Flexion Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.